162 related articles for article (PubMed ID: 25354788)
1. Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management.
Lalani J; Patil S; Kolate A; Lalani R; Misra A
AAPS PharmSciTech; 2015 Apr; 16(2):413-27. PubMed ID: 25354788
[TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
4. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
Lalani J; Rathi M; Lalan M; Misra A
Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
[TBL] [Abstract][Full Text] [Related]
5.
Nigam K; Kaur A; Tyagi A; Manda K; Goswami N; Nematullah M; Khan F; Gabrani R; Gauba P; Dang S
J Microencapsul; 2022 Mar; 39(2):95-109. PubMed ID: 35147068
[TBL] [Abstract][Full Text] [Related]
6. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
7. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study.
Shah P; Dubey P; Vyas B; Kaul A; Mishra AK; Chopra D; Patel P
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):511-522. PubMed ID: 34151674
[TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.
Yu Y; Pang Z; Lu W; Yin Q; Gao H; Jiang X
Pharm Res; 2012 Jan; 29(1):83-96. PubMed ID: 21979908
[TBL] [Abstract][Full Text] [Related]
13. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Zheng Y; Yu B; Weecharangsan W; Piao L; Darby M; Mao Y; Koynova R; Yang X; Li H; Xu S; Lee LJ; Sugimoto Y; Brueggemeier RW; Lee RJ
Int J Pharm; 2010 May; 390(2):234-41. PubMed ID: 20156537
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.
Li M; Panagi Z; Avgoustakis K; Reineke J
Int J Nanomedicine; 2012; 7():1345-56. PubMed ID: 22419876
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
[TBL] [Abstract][Full Text] [Related]
16. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
Shah PP; Desai PR; Singh M
J Control Release; 2012 Mar; 158(2):336-45. PubMed ID: 22134117
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
18. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
19. Baclofen-Loaded Poly (D,L-Lactide-Co-Glycolic Acid) Nanoparticles for Neuropathic Pain Management:
Nigam K; Kaur A; Tyagi A; Manda K; Gabrani R; Dang S
Rejuvenation Res; 2019 Jun; 22(3):235-245. PubMed ID: 30175946
[TBL] [Abstract][Full Text] [Related]
20. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
